SG Americas Securities, LLC
Broker-DealerPosition in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1313360
NEW YORK, NY
Position in CRNX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$943,358
+$595,740 QoQ
Shares Held
25,210
+163.4% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#125
of 264 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. CRNX ranks #76 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in CRNX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $943,358 | 25,210 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $347,618 | 9,571 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,014,277 | 21,789 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $1,344,087 | 32,271 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $583,310 | 20,282 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $17,516,801 | 522,266 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $27,735,263 | 542,446 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $662,409 | 12,963 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $3,540,694 | 79,051 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $279,315 | 5,967 | Shares | Sole | 2024-05-06 | |
| 2023-03-31 | $420,225 | 26,166 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $178,736 | 9,767 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $301,002 | 15,326 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $473,560 | 25,392 | Shares | Sole | 2022-07-29 | |
| 2021-12-31 | $180,858 | 6,366 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $405,570 | 19,267 | Shares | Sole | 2021-11-01 | |
| 2020-06-30 | $259,331 | 14,802 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||